PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Vaccine10.1016/j.vaccine.2008.09.091200927182523-2528Immunogenicity of recombinant protective antigen and efficacy against intranasal challenge with Bordetella bronchisepticaZhanqin Zhao, Yun Xue, Xibiao Tang, Bin Wu, Xiangchao Cheng, Qigai He, Chunjie Zhang, Aizhen Guo, Meilin Jin, Huanchun Chenhttps://api.elsevier.com/content/article/PII:S0264410X08013212?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X08013212?httpAccept=text/plain
Vaccine10.1016/0264-410x(92)90017-e1992103199Protecting against Bordetella pertussis or Bordetella bronchiseptica using native, recombinant vaccine consisting of 69 kDa outer membrane protein or filamentous hemagglutinin protein purified from B. pertussis, Bordetella parapertussis or B. bronchisepticahttps://api.elsevier.com/content/article/PII:0264410X9290017E?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X9290017E?httpAccept=text/plain
Vaccine10.1016/0264-410x(90)90070-3199083291Vaccine against Bordetella pertussis infection comprises Bordetella bronchiseptica pilus subunit proteinhttps://api.elsevier.com/content/article/PII:0264410X90900703?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X90900703?httpAccept=text/plain
Vaccine10.1016/0264-410x(90)90263-l199085511Bordetella bronchiseptica vaccine; comprises whole B. bronchiseptica cells obtained from liquid culture and inactivated with glutaraldehydehttps://api.elsevier.com/content/article/PII:0264410X9090263L?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X9090263L?httpAccept=text/plain
Vaccine10.1016/j.vaccine.2004.04.02020042231-324300-4305Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgCAndrew Stevenson, Mark Robertshttps://api.elsevier.com/content/article/PII:S0264410X04003652?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X04003652?httpAccept=text/plain
Vaccine10.1016/0264-410x(89)90027-319897179-80Bordetella bronchiseptica vaccine production by fermentation under specified conditionshttps://api.elsevier.com/content/article/PII:0264410X89900273?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X89900273?httpAccept=text/plain
Vaccine10.1016/s0264-410x(01)00226-2200119324842-4850Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragmentSreekumari Rajeev, Stephen A. Kania, Rajeev V. Nair, Jack T. McPherson, Robert N. Moore, David A. Bemishttps://api.elsevier.com/content/article/PII:S0264410X01002262?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X01002262?httpAccept=text/plain
Vaccine10.1016/0264-410x(89)90025-x19897179Production of Bordetella bronchiseptica mutants for production of vaccine against atrophic rhinitishttps://api.elsevier.com/content/article/PII:0264410X8990025X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X8990025X?httpAccept=text/plain
Biotechnology Advances10.1016/0734-9750(90)91493-z1990824554857318 Bordetella bronchiseptica pilus subunit protein vaccine effective against bordetella pertussishttps://api.elsevier.com/content/article/PII:073497509091493Z?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:073497509091493Z?httpAccept=text/plain
Biotechnology Advances10.1016/0734-9750(90)91440-r1990824454888169 Bordetella bronchiseptica vaccinehttps://api.elsevier.com/content/article/PII:073497509091440R?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:073497509091440R?httpAccept=text/plain